S&P 500
7,226.20
+0.01%
Dow Jones
49,494.60
-0.62%
Nasdaq 100
27,685.40
+0.66%
Russell 2000
2,804.78
-0.02%
FTSE 100
10,364.50
0.00%
Nikkei 225
59,260.50
-0.78%

Investing

LQDA logo Liquidia : LQDA

LQDA

Stock Data

$38.14

Change down

$1.07 (2.73%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

DRUG MANUFACTURERS - SPECIALTY & GENERIC

Liquidia Corp is a biopharmaceutical firm based in Morrisville, North Carolina, focusing on creating innovative treatments for patients with unmet medical needs. Its flagship product, YUTREPIA, is an inhaled dry powder version of treprostinil designed to address pulmonary arterial hypertension. Additionally, the company offers a generic treprostinil injection, expanding its impact on patient care. Founded in 2004, Liquidia continues to pioneer in the healthcare sector, aiming to improve quality of life through advanced medical solutions.

All Liquidia Articles

2 Articles